Emerson Andrew sold IDXX
February 12, 2026 · Form 4 insider transaction
Emerson Andrew sold 65 shares of IDEXX Laboratories, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
65
Price
$0.00
Total value
N/A
InsiderEmerson Andrew
Role—
SecurityRestricted Stock Unit
Transaction codeM: Option exercise
Transaction dateFebruary 12, 2026
Filing dateFebruary 17, 2026
Shares owned after193
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan.